Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...

Although breast cancer is the most common non-skin cancer diagnosed in women, finding support during treatment and through survivorship can be...

Non-melanoma skin cancer (NMSC) is the most common type of cancer. NMSC treatment can be painful and cause scarring. Rhenium-SCT® is a non-invasive...

Prostate cancer is the second most common cancer in men worldwide. Despite medical advances in recent years, this type of tumour is still...

Immunotherapies that mobilise a patient’s immune system to fight cancer have become a treatment pillar. These therapies, including CAR T-cell...

In a breakthrough study published in Cell Reports, researchers from Professor Idit Shachar’s laboratory at the Weizmann Institute of Science have...

Scientists have created a 3D-printed model to mimic the specific conditions that spur the spread of cancer cells. The model, published in the...

Beata Halassy, ​​a virologist from the University of Zagreb, has successfully treated herself with breast cancer using a virus she developed...

The risks of adverse effects and complications from treatment for prostate cancer are substantial and continue for years after treatment ends.

THURSDAY, Nov. 7, 2024 -- Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a new...